# Sequenom, Inc. clinical trials: 26 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 26 trials with Sequenom, Inc. as lead sponsor, 4 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Sequenom, Inc.: 26 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/sequenom-inc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 26
- Recruiting or not yet: 4
- Read on: November 19, 2026

## Trials

The 25 newest of 26, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| April 22, 2026 | NCT07543757 | Prostate Cancer Risk Identification in a Multi-Ethnic Cohort: a Prospective US-based Multi-center Validation Study of Proclarix | Sequenom, Inc. | Observational | Recruiting | Prostate Cancer Detection | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07543757) |
| October 16, 2024 | NCT06643741 | Non-Invasive Preeclampsia Screening and Biobank | Sequenom, Inc. | Observational | Recruiting | Preeclampsia (PE) | 6,550 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06643741) |
| August 23, 2023 | NCT06008457 | Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit | Sequenom, Inc. | Observational | Completed | COVID-19 Respiratory Infection, Influenza A, Influenza Type B, RSV Infection | 1,600 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06008457) |
| March 1, 2021 | NCT04774640 | Development of a NIPTT for Detecting Copy Number Variations | Sequenom, Inc. | Observational | Terminated | Copy Number Variations | 9 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04774640) |
| October 20, 2020 | NCT04595201 | Clinical Follow-up of Pregnant Subjects Undergoing NIPT | Sequenom, Inc. | Observational | Completed | Pregnancy | 20,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04595201) |
| April 28, 2020 | NCT04364503 | Compliant Analysis of Patient Samples and Data | Sequenom, Inc. | Observational | Enrolling by invitation | Pregnancy Related, Cancer, Infectious Disease | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04364503) |
| January 18, 2019 | NCT03810144 | Impact of Guided Care With the Vectra Multi-biomarker Disease Activity (MBDA) Blood Test | Sequenom, Inc. | Observational | Completed | Rheumatoid Arthritis | 444 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03810144) |
| August 15, 2018 | NCT03631225 | The Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis | Sequenom, Inc. | Observational | Completed | Rheumatoid Arthritis (RA) | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03631225) |
| October 26, 2015 | NCT02586389 | Specimen Collection From Patients With Non-Hematologic Cancer for Use in Development of a Liquid Biopsy Assay | Sequenom, Inc. | Observational | Recruiting | Non-hematologic Cancer | 3,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02586389) |
| August 27, 2014 | NCT02226315 | Clinical Performance of the MaterniT21 PLUS LDT in Multiple Gestation Pregnancies | Sequenom, Inc. | Observational | Terminated | Down Syndrome, Edwards Syndrome, Patau Syndrome, Turner Syndrome | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02226315) |
| June 19, 2013 | NCT01880788 | Genetic Analysis of Chronic Central Serous Chorioretinopathy Masquerading as Neovascular AMD | Sequenom, Inc. | Observational | Completed | Age Related Macular Degeneration, Choroidal Neovascularization, Central Serous Chorioretinopathy | 152 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01880788) |
| April 19, 2013 | NCT01835483 | Determination of Performance Characteristics of the MassPLEX Factor II/V Leiden Test | Sequenom, Inc. | Observational | Completed | Factor V Leiden, Factor II, Thrombosis | 867 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01835483) |
| September 10, 2012 | NCT01682382 | Association of Macular Pigment Optical Density (MPOD) and Genetic Variants in Complement Factor H in Subjects With Choroidal Neovascular... | Sequenom, Inc. | Observational | Completed | Age-related Macular Degeneration, Choroidal Neovascular Age-related Macular Degeneration | 45 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01682382) |
| July 26, 2012 | NCT01650948 | Genetic Load and Phenotype in Aggressive AMD | Sequenom, Inc. | Observational | Completed | Age-related Macular Degeneration | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01650948) |
| July 19, 2012 | NCT01644513 | Evaluation of the Association Between Genetic Load and Response to Anti-VEGF Therapy in AMD Patients | Sequenom, Inc. | Observational | Completed | Age Related Macular Degeneration | 196 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01644513) |
| May 11, 2012 | NCT01597063 | Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies | Sequenom, Inc. | Observational | Completed | Aneuploidy, Down Syndrome, Noninvasive Prenatal Screening | 3,333 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01597063) |
| March 15, 2012 | NCT01555346 | Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies | Sequenom, Inc. | Observational | Completed | Down Syndrome, Fetal Aneuploidy | 3,062 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01555346) |
| September 7, 2011 | NCT01429389 | Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy | Sequenom, Inc. | Observational | Recruiting | Down Syndrome, Fetal Aneuploidy | 2,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01429389) |
| January 22, 2010 | NCT01054716 | Evaluation of a Noninvasive Fetal RHD Genotyping Test | Sequenom, Inc. | Observational | Completed | Rhesus D Genotype | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01054716) |
| January 20, 2010 | NCT01052688 | Noninvasive Screening for Affected Pregnancies: Assay Development & Optimization in Affected Pregnancies | Sequenom, Inc. | Observational | Completed | Down Syndrome, Aneuploidy | 150 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01052688) |
| November 26, 2009 | NCT01021085 | Evaluation of Fetal Sex in Assisted Reproductive Technology (ART) Achieved Pregnancies | Sequenom, Inc. | Observational | Completed | Fetal Sex Determination | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01021085) |
| September 3, 2009 | NCT00971334 | Noninvasive Screening for Fetal Aneuploidy: A New Maternal Plasma Marker | Sequenom, Inc. | Observational | Completed | Pregnancy, Aneuploidy, Down Syndrome, Edwards Syndrome | 2,502 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00971334) |
| September 2, 2009 | NCT00970047 | Development of a Fetal Sex Assay From Maternal Whole Blood | Sequenom, Inc. | Observational | Completed | Fetal Sex Determination | 500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00970047) |
| March 30, 2009 | NCT00871195 | A Noninvasive Test for Fetal RHD Genotype | Sequenom, Inc. | Observational | Completed | Rhesus D Genotype | 520 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00871195) |
| February 20, 2009 | NCT00847990 | Non-Invasive Screening for Fetal Aneuploidy | Sequenom, Inc. | Observational | Completed | Down Syndrome, Edwards Syndrome | 5,000 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00847990) |

## By phase

| Phase | Trials |
| --- | --- |
| Observational | 26 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 19 |
| Recruiting | 4 |
| Terminated | 2 |
| Enrolling by invitation | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Down Syndrome | 8 |
| Aneuploidy | 4 |
| Trisomy 18 Syndrome | 4 |
| Macular Degeneration | 4 |
| Trisomy | 3 |
| Trisomy 13 Syndrome | 2 |
| Turner Syndrome | 2 |
| Arthritis, Rheumatoid | 2 |
| Neoplasms | 1 |
| Communicable Diseases | 1 |
| Respiratory Syncytial Virus Infections | 1 |
| Thrombosis | 1 |
| Pre-Eclampsia | 1 |
| Choroidal Neovascularization | 1 |
| Central Serous Chorioretinopathy | 1 |
| Chromosome Aberrations | 1 |
| Prostatic Neoplasms | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Lumber stores in the United States](https://specstream.ai/data/businesses/lumber-stores/united-states)
- [Periodontics practices in the United States](https://specstream.ai/data/businesses/periodontics-practices/united-states)
- [Shoe factory manufacturers in the United States](https://specstream.ai/data/businesses/shoe-factory-manufacturers/united-states)
- [Video production companies in the United States](https://specstream.ai/data/businesses/video-production-companies/united-states)
- [B2B mining companies in the United States](https://specstream.ai/data/businesses/b2b-mining-companies/united-states)
- [Civil engineering firms in the United States](https://specstream.ai/data/businesses/civil-engineering-firms/united-states)
